Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 7.37
-1.47 %
$ 399 M
Market Cap
-1.88
P/E
EBS - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities EBS - Emergent BioSolutions Inc.
212 M
LAST VALUE
71.57%
2 YEAR CAGR
17.47%
5 YEAR CAGR
17.76%
10 YEAR CAGR